Tag

Global Health Equity

All articles tagged with #global health equity

HIV Prevention Breakface: Lenacapavir’s Efficacy Meets Access Barriers
health12 days ago

HIV Prevention Breakface: Lenacapavir’s Efficacy Meets Access Barriers

A twice-yearly HIV prevention injection, lenacapavir, showed zero infections in a 2024 trial of over 2,000 women in South Africa and Uganda. While the World Health Organization recommends it as pre-exposure prophylaxis, access remains uneven. The US price is $28,000 annually, while generics are expected to cost $40. However, 26 middle-income countries, including Brazil and Mexico, are excluded from generic licensing deals, and international HIV funding dropped 18% in 2025.

"Lessons for Britain from India's 'Vaccine Prince'"
global-health-security2 years ago

"Lessons for Britain from India's 'Vaccine Prince'"

Adar Poonawalla, CEO of Serum Institute of India, emphasizes the importance of investing in vaccine manufacturing facilities to prepare for future pandemics, warning that political will is fading post-Covid. The institute, known as the "pharmacy of the world," is expanding its focus to prepare for potential future pandemics, with a two-pronged approach involving stockpiling and rapid manufacturing capabilities. While efforts in Europe to enhance vaccine manufacturing capacity are proactive, the UK is criticized for its lack of political interest in this area. Poonawalla stresses the need for diverse global manufacturing capabilities to avoid supply-chain issues and ensure equitable access to vaccines, emphasizing the commitment to fair distribution and global health equity.

"Addressing the Disparity: Improving Access to Clinical Trials for Cancer Patients"
healthcare3 years ago

"Addressing the Disparity: Improving Access to Clinical Trials for Cancer Patients"

Less than 5% of cancer patients worldwide have access to clinical trials, hindering the progress in finding a cure for cancer. Dr. Bob Li, a physician ambassador and medical oncologist, emphasizes the need for global coordination and addressing the issue of inequity in access to breakthrough research. He believes that clinical trials are crucial in translating scientific discoveries into life-saving treatments, but the low percentage of patients participating in trials leads to an excessively long research and development timeline. Efforts are being made to improve access to trials, such as partnerships between institutions and harmonization of trials and drug approvals.